LNTH News and Press, Lantheus Holdings Inc. From 10/20/22

NORTH BILLERICA, Mass., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, November 3, 2022, to discuss its financial and operating results fo...

NORTH BILLERICA, Mass., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow dis...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips “How would you like to make 10x on your investment?” Ordinarily, you and I would respond with deep skepticism. Such questions are usually followed by a multi-level marketing ( MLM ) pitch, a link to a ques...

Targa Resources Set to Join S&P 500; Lantheus Holdings to Join S&P MidCap 400; Payoneer Global to Join S&P SmallCap 600 Targa Resources Set to Join S&P 500; Lantheus Holdings to Join S&P MidCap 400; Payoneer Global to Join S&P SmallCap 600 PR Newswire...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Before jumping directly into momentum stocks worth buying now, it’s important to understand what momentum trading is. As the name implies, momentum trading relies on reacting to the current movement of a stock ...

Summary Today, we put the spotlight on Lantheus Holdings for the first time. The stock has been a big winner in 2022 thanks to the impressive growth racked up by recently launched imaging agent Pylarify. Can the good times continue for shareholders? An investment analysis foll...

Phase III clinical trial of [ 18 F]flurpiridaz PET diagnostic radiopharmaceutical meets co-primary endpoints for detecting Coronary Artery Disease (CAD) Trial also met its first key secondary endpoint, demonstrating higher diagnostic efficacy for [ 18 F]flurpiridaz PET compare...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips For those investors interested in small-cap stocks to buy, you might steer clear of tech names. At least, that’s according to the analysts at Jefferies .  Jefferies analyst Steven DeSanctis recently dis...

NORTH BILLERICA, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc . (“the Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative diagnostics, targeted therapeutics and artificial intelligence solutions that...

B Riley has resumed coverage of Lantheus Holdings ( NASDAQ: LNTH ) with a buy citing the company's growth trajectory due to the the launch of Pylarify, a prostate-specific membrane antigen (PSMA) targeting positron emission tomography ( PET ) imaging agent. The firm ha...